kstew updat arjo read-thru hillrom
morn arjo arjo ss cover report result arjo sw edish medic devic compani focus medic
bed patient handl lift stand chair therapeut surfac vte solut person hygien product arjo
competitor hillrom result comment lead us maintain overweight rate hillrom underweight
rate
arjo coverag barclay research inform compani provid inform purpos
invest recommend barclay research
way case miss late friday publish kstew updat outpati visit data point
interest recent data point commonwealth fund provid well data kaiser famili
foundat econom impact check note interest data point chart
arjo note continu see higher demand capit medic bed busi though see low er
demand patient handl busi note patient handl smaller busi hillrom herea larger
market share exposur patient handl em stretcher medic busi arjo also note start see
elect surgeri start come back germani
arjo report follow ing ith respect hillrom believ north america unit relev geographi
overal north america hile us busi
arjo note increas demand medic bed therapeut mattress rental includ critic solut unit
state product capac medic bed therapeut mattress increas meet demand
arjo comment see declin patient handl hygien servic instal start see declin
 limit access hospit long term care facil later march follow ing good start januari februari
western europ organ grow th arjo note march ere sever market show ed uptick sale
demand medic bed therapeut mattress like north america servic instal impact limit access
hospit long term care facil low er demand categori directli relat patient
handl hygien
rest world revenu declin posit first tw month arjo note effect march led overal
declin regard impact march saw grow th primarili held back postpon instal project
australia distribut market eastern europ also note india saw signific declin total lockdow
outlook commentari manag note ell last year order intak quarter backlog invoic
run year higher last year moment havent lost order postpon need follow
develop daili basi build unnecessari inventori short term demand bed therapeut mattress
high ith net sale ell forecast begin rental busi develop ell core
critic care unit base today situat continu ell middl unpreced situat
access healthcar facil limit elect surgeri postpon mani countri hich affect consult sale
servic ell prevent mainten hich ill affect patient handl hygien dvt hich effect best
assumpt return normal ill depend hen countri open hich someth predict ith accuraci
manag believ outlook someth abl offer ith precis sinc cant paus
guidanc ill look provid updat hen better visibl note good indic hat expect arjo
normal circumst
 commentari confer call manag made remark regard
mani european countri took proactiv measur earlier march note start see elect
surgeri pick back germani manag note countri discuss open clinic discuss
 ill icu retain treatment rest elect surgeri
regard net effect covid sale manag said reluct say ould posit impact overal
sale expect see notabl declin invoic sell patient handl hygien dvt servic
 see manag comment see uptick medic bed ell manag
forecast capit sale medic bed sek yearli basi compar patient handl big
percentag sale note put capit medic bed total sale manag note see
uptick rental product overal hich turnov good job rental current ill eigh
part ould reluct say ill posit impact rememb last year saw organ
uptick ith even ith big kindr order quarter difficult comp
illustr arjo sale mix geographi custom product mix latest avail year
sale geographi
sale custom categori
arjo sale product categori last avail data
thought hillrom continu rate overweight
hillrom report result friday may
march hillrom announc busi oper ere continu ith materi interrupt global demand sever
critic product grow substanti compani note ork signific ramp product product demand
 ith goal doubl capac certain area note specif
respiratori health especi non-invas ventil hillrom note ork increas product capac
five-fold annual basi note april depart human servic announc
final contract ith hillrom price million ventil produc juli ith june thu
bulk revenu ill recogn hillrom
icu med-surg unit smart bed hillrom note includ progressa icu bed hich premium price product
centrella smart bed intern market hillrom hillrom acella
patient monitor diagnost product hillrom note includ connex vital sign monitor ell physic
assess tool consum includ thermometri probe cover blood pressur devic cuff
april also announc five new devic connect advanc ell updat clinic protocol relat covid-
thought continu rate underweight
report result april
march issu ithdraw ing full year organ sale grow th ep guidanc cite uncertainti
relat potenti implic hich note could materi
 believ like feel pressur across busi elect procedur base ell capit
sale product categori
sale region
alway stay safe stay healthi well kind
feel free reach
access note barclay live click titl report blue text
believ great read deep dive examin near potenti long-term rippl effect think
investor visual novel coronaviru giant boulder throw lake creat big initi
splash upon entri rippl ill seen felt reach far shore time initi focu
investor commun big splash creat near-term effect import question difficult
answ er hat effect rippl hat long-term impact healthcar industri
 holeprovid physician patient insur cours med-tech compani report aim
 healthcar physician survey reduc offic visit procedur across multipl specialti barclay
global healthcar survey physician state across differ sub-specialti includ intervent
endocrinolog dermatolog neurolog hemo-oncolog rheumatolog evalu impact practic trend
particularli offic volum elect procedur prescript pattern nearli physician report signific declin
patient offic visit averag visit around primari reason behind declin appear
patient cancel visit telehealth appoint significantli perhap enough off-set declin in-person
visit major physician indic facil hospit asc offices/surgi-cent implement
polici cancel elect procedur led signific reduct surgeri report list common
elect procedur specialti cancel usual suspect like knee hip replac arthroscopi radiofrequ
ablat nerv block spinal fusion stent etc ere list think list greater might think
includ procedur like valv replac tavr laa prevent icd pacemak cabg peripher intervent
endoscopi prostatectomi db also talk implic med-tech
 medic suppli devic put take isrg-get readi arn flag insid
reportw review med-tech takeaw ay barclay global healthcar confer discuss american colleg
surgeon surgeon gener recommend cancel elect procedur review state health system
hospit taken action limit elect procedur action relev medic devic includ
commentari regard build new bed review hat elect procedur discuss product mix compani
 review hat product could use effort compani manufactur product
kstew updat outpati visit data point interest recent data point courtesi
commonw ealth fund ell data kaiser famili foundat outpati visit econom impact
data point continu reinforc cautiou view prospect recoveri elect procedur
kstew updat call tidbit read-thru quest geting roch -- bdx/syk ant pass along
tidbit earn call today quest cover meehan geting cover roch cover
emmanuel papadaki relev coverag univers ant highlight tw particular read-thru
one hich get frequent question rate equal eight
underw eight
 kstew updat first look bad number may look like even
provid updat result hich end april net/net impact signific neg
despit even product line like ventil patient monitor devic higher demand ith
 believ new like eigh stock short term other med-tech sector
kstew updat call tidbit read-thru med-tech cover steve
valiquett releas result morn ant pass along comment made
earn call morn provid read-through medic devic suppli univers highlight tw
name particular-conm cnmd-overw eight syk-underw eight
kstew updat philip read-thru med-tech maintain ow uw philip phia na cover
hassan al-w akeel eu med-tech servic analyst report result philip provid read-thru coverag
univers particularli compani ith hospit capital-expenditure commentari lead us reaffirm overw eight rate hillrom
hrc-report result may underw eight rate report result april
kstew updat hen open or ill come look open america open
america guidelin includ framew ork around restart elect procedur phased-in approach view
still lot open question decis hand individu state hen restart hen
allow elect procedur still yet individu hospit implement restart
kstew updat baxter updat read-thru serolog test vent contract updat ant
highlight coupl updat tonight baxter see increas demand across certain product serolog test
updat landscap vent contracts- provid updat contract hillrom contract price million
 view amount hillrom posit give us addit confid outlook thesi
kstew updat urgent deferr thought procedur edit review
procedur -- commentari provid manag journal articl stemi heart attack procedur state elect
order elect procedur
kstew updat count eather cdc outlin return ork guidelin present
find nation academi scienc engin medicin committe find relat
temperatur humid potenti season
kstew updat ny apex vent updat abt dx airtim presid trump other
updat discuss updat ny state trend updat hite hous press brief
ventil ell abbott test
hill-rom hold inc upgrad overw eight readi abl assist ith estim least
hillrom sale rental bed legaci elch allyn product thermometri patient monitor blood pressur
physic examin product could use help triag assess monitor aid treatment patient hillrom
also recent acquir hich non-invas ventil anoth hillrom busi
acut care frame hich includ icu bed mani hospit state cite shortag
kstew updat aim doubl capac global demand reiter ow reiter
overw eight rate hillrom market close hillrom announc global demand sever critic product
grow substanti ork significantli ramp product ith goal doubl capac
follow ing area respiratori health icu med-surg smart bed patient monitor diagnost
kristen stew art cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens
 ill directli indirectli relat specif recommend view express research report
barclay capit inc and/or one affili seek busi ith compani cover research report
result investor aw firm may conflict interest could affect object report investor
consid report singl factor make invest decis
barclay research produc invest bank barclay bank plc affili collect individu
barclay author contribut research report research analyst unless otherw ise indic public date
top report reflect local time report produc may differ releas date provid gmt
avail disclosur
 compani subject research report current import disclosur regard compani pleas
refer http //publicresearch barclay com altern send ritten request barclay research complianc seventh
avenu floor new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ
firm total revenu portion hich gener invest bank activ profit revenu market
busi potenti interest firm invest client research ith respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit
accept payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link
analysi quantit analysi trade idea recommend contain one type barclay research may differ
contain type barclay research hether result differ time horizon methodolog otherw ise
order access barclay statement regard research dissemin polici procedur pleas refer
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas
refer http //publicresearch barcap com/s/cm htm
master limit partnership mlp pass-through entiti structur publicli list partnership tax purpos
distribut unit holder may treat return princip investor consult ow tax advisor
invest unit
co usd equal eight/neutr a/cd/ce/d/e/j/k/l/m/n
valuat methodolog set price target primarili reli forw ard price-to-earnings methodolog price target
appli price-to-earnings multipl calendar year ep
risk may imped achiev barclay research valuat price upsid new product drive
acceler sale ep grow th accret acquisit continu favor hospit capital-expenditure environ
nside less favor trend hospit capital-expenditure delay due slow er uptak new product strengthen us
dollar higher tax rate risk includ signific reimburs chang fda product approv time competit
pressur fda govern action
rate price target histori
prior intra-day chang may publish rate secur overw eight
adjust price target
histor stock price price target may adjust stock split dividend
valuat methodolog set price target primarili reli forw ard price-to-earnings methodolog price target
appli pe multipl ep estim expect multipl compress ow ing elect procedur
capital-expenditure exposur underli sale grow th slow
risk may imped achiev barclay research valuat price fx rate recent acquisit
could pressur earn grow th competit pressur particularli area knee competitor launch compet
robotic-assist system could impact grow th outlook sentiment tow ard stock time ultim receipt new
product approv could affect outlook risk includ integr right acquisit signific chang
reimburs potenti dilut associ ith acquisit product failur fda govern action
deterior cash flow could also risk factor
rate price target histori
prior intra-day chang may publish rate secur underw eight
adjust price target
histor stock price price target may adjust stock split dividend
unless otherw ise indic price sourc bloomberg reflect close price relev trade market hich
may last avail price time public
